Completion of the clinical phase of randomized, double blind, placebo controlled pilot study conducted in India to evaluate safety and efficacy of orally administered IMA001 in sickle cell disease patients.
Imalia Announces Completion of Clinical Phase of Indian Randomized Pilot Study on IMA001 in Sickle Cell Disease
Completion of the clinical phase of randomized, double blind, placebo controlled pilot study conducted